Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 4 of 4 for “"Burkitt-like lymphoma"”.
-
Burkitt and Burkitt-like lymphoma/leukaemia at Groote Schuur Hospital from 2005 to 2014: a retrospective review
… is at increased risk of developing non-Hodgkin lymphoma, particularly high grade aggressive subtypes such as Burkitt- and Burkittlike lymphoma (also known as B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma). Methods: Ten year …
-
Hematologic parameters and bone marrow flow cytometry features in patients with GATA2 and RUNX1 germline mutations ; Evaluation of frequency of 11q aberrations in patients with Burkitt-like lymphoma and other aggressive B cell lymphomas: correlation with histopathology and clinical characteristics
… development of effective screening strategies. Burkitt-like lymphoma with 11q aberration (BLL-l1q) is one of the newly described provisional entities with morphologic features, immunophenotype, and gene expression profile similar to Burkitt lymphoma (BL) but lacks MYC rearrangement. Whether this …
-
Identification and characterization of pathogenetically relevant genes in mature aggressive B-cell lymphomas of childhood by a combination of genomic and functional analyses
Burkitt lymphomas (BL) account for about 25 % of the mature B-cell lymphomas in childhood. The hallmark of BL is the chromosomal translocation t(8;14)(q24;q32), juxtaposing the MYC gene to the immunoglobulin (IG) heavy chain locus, or one of its light chain variants. These translocations result in …
-
Gcn5 Loss Impacts Myc-Driven Cancer In Mice and Human Cells
… in Triple negative breast cancer cells. Burkitt lymphoma is an aggressive subtype of Non-Hodgkin’s lymphoma driven by the overexpression of c-MYC. In this dissertation we show inhibition of GCN5 reduces MYC-driven gene expression in Burkitt lymphoma and therefore reduces cancer phenotypes …